4//SEC Filing
Krempa David 4
Accession 0001437749-24-004361
CIK 0001710340other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:17 PM ET
Size
5.3 KB
Accession
0001437749-24-004361
Insider Transaction Report
Form 4
Krempa David
Chief Business Officer
Transactions
- Award
Stock Option (Right to buy)
2024-02-13+144,677→ 813,430 totalExercise: $4.42Exp: 2034-02-12→ Common Stock (144,677 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 13, 2028.
Documents
Issuer
Eton Pharmaceuticals, Inc.
CIK 0001710340
Entity typeother
Related Parties
1- filerCIK 0001968254
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:17 PM ET
- Size
- 5.3 KB